(Q38087697)

28 August 2017

The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations (English)

1 reference

chronic obstructive pulmonary disease

28 August 2017

0 references

1 reference

1 reference

asthma-chronic obstructive pulmonary disease overlap syndrome

0 references

author name string

Samuel Louie

1

1 reference

28 August 2017

Amir A Zeki

2

1 reference

28 August 2017

Michael Schivo

3

1 reference

28 August 2017

Andrew L Chan

4

1 reference

28 August 2017

Ken Y Yoneda

5

1 reference

28 August 2017

Mark Avdalovic

6

1 reference

28 August 2017

Brian M Morrissey

7

1 reference

28 August 2017

Timothy E Albertson

8

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

Expert Review of Clinical Pharmacology

28 August 2017

1 reference

28 August 2017

6

1 reference

28 August 2017

2

1 reference

28 August 2017

197-219

1 reference

The overlap syndrome of asthma and COPD: what are its features and how important is it?

28 August 2017

1 reference

The clinical features of the overlap between COPD and asthma

21 January 2018

1 reference

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

21 January 2018

1 reference

Consensus document on the overlap phenotype COPD-asthma in COPD.

21 January 2018

1 reference

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

Bronchodilator responsiveness in patients with COPD.

21 January 2018

1 reference

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome

21 January 2018

1 reference

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

Asthmatic granulomatosis: a novel disease with asthmatic and granulomatous features

21 January 2018

1 reference

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease

21 January 2018

1 reference

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

21 January 2018

1 reference

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies

21 January 2018

1 reference

Developing COPD: a 25 year follow up study of the general population

21 January 2018

1 reference

Asthma and cigarette smoking.

21 January 2018

1 reference

Global burden of COPD: risk factors, prevalence, and future trends

21 January 2018

1 reference

There is no such thing as aging

21 January 2018

1 reference

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention.

21 January 2018

1 reference

Mortality in relation to smoking: 50 years' observations on male British doctors

21 January 2018

1 reference

Gender difference in smoking effects on adult pulmonary function.

21 January 2018

1 reference

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

Vaccines against drug abuse

21 January 2018

1 reference

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

21 January 2018

1 reference

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

21 January 2018

1 reference

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

21 January 2018

1 reference

The role of long-acting bronchodilators in the management of stable COPD.

21 January 2018

1 reference

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

21 January 2018

1 reference

Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.

21 January 2018

1 reference

The pharmacological properties of tiotropium

21 January 2018

1 reference

Improvements with tiotropium in COPD patients with concomitant asthma

21 January 2018

1 reference

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

21 January 2018

1 reference

Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.

21 January 2018

1 reference

Emerging inhaled bronchodilators: an update

21 January 2018

1 reference

The properties of inhaled corticosteroids: similarities and differences.

21 January 2018

1 reference

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

21 January 2018

1 reference

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial

21 January 2018

1 reference

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

21 January 2018

1 reference

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study

21 January 2018

1 reference

Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization

21 January 2018

1 reference

Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review

21 January 2018

1 reference

Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

21 January 2018

1 reference

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

21 January 2018

1 reference

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

21 January 2018

1 reference

Theophylline: new perspectives for an old drug

21 January 2018

1 reference

Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

21 January 2018

Theophylline for COPD.

1 reference

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

21 January 2018

1 reference

Azithromycin for prevention of exacerbations of COPD.

21 January 2018

1 reference

Azithromycin and the risk of cardiovascular death

21 January 2018

1 reference

Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report

21 January 2018

1 reference

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program

21 January 2018

1 reference

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

21 January 2018

1 reference

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

21 January 2018

1 reference

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial

21 January 2018

1 reference

Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena

21 January 2018

1 reference

Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable

21 January 2018

1 reference

The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly

21 January 2018

1 reference

12 December 2020

Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency

1 reference

12 December 2020

The impact of chronic obstructive pulmonary disease on work loss in the United States

1 reference

12 December 2020

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

12 December 2020

Summary health statistics for U.S. adults: National Health Interview Survey, 2005.

1 reference

12 December 2020

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

1 reference

12 December 2020

Tiotropium in asthma poorly controlled with standard combination therapy

1 reference

12 December 2020

Cigarette smoking among adults--United States, 2007

1 reference

12 December 2020

Counterpoint: evidence-based medicine lacks a sound scientific base

1 reference

12 December 2020

Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy

1 reference

12 December 2020

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

1 reference

12 December 2020

Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party

1 reference

12 December 2020

Summary health statistics for U.S. adults: National Health Interview Survey, 2010.

1 reference

12 December 2020

Anticholinergic agents for chronic asthma in adults

1 reference

12 December 2020

Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment

1 reference

12 December 2020

The FDA and safe use of long-acting beta-agonists in the treatment of asthma

1 reference

12 December 2020

Deaths: final data for 2008.

1 reference

12 December 2020

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

1 reference

12 December 2020

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

12 December 2020

Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences

1 reference

12 December 2020

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update

1 reference

12 December 2020

Identifiers

DOI

10.1586/ECP.13.2

1 reference

28 August 2017

1 reference